Thu, Mar 18, 2021 11:30 AM – 12:30 PM EDT


Automated data networks are transforming prospective research by adding value in ways not possible with traditional registries. This webinar challenges the status quo and explores innovative approaches to building and leveraging data networks for succeeding in the new world of real-world data and multi-stakeholder requirements.

Join Dr. Richard Gliklich, CEO of OM1, as he explores:

– Comparing traditional prospective research with the newer data network approach
– Applying real-world data for pharmacovigilance
– Making data regulatory-grade for submissions and post-marketing commitments
– Case examples in immunology, dermatology, cardiometabolic, and ENT


**Please be advised this webinar is intended for pharmaceutical and medical device companies. Due to the proprietary nature of the content, all registration approval is at the discretion of OM1. Vendors and consultants will not be permitted to attend at this time.